We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $7.48B
1-Year Est. Return 104.76%
This Fund
S&P 500
This Quarter Est. Return
+28.17%
1 Year Est. Return
+104.76%
3 Year Est. Return
+313.12%
5 Year Est. Return
+388.67%
10 Year Est. Return
+3,437.54%
AUM
$3.55B
AUM Growth
+$522M
Cap. Flow
-$54.7M
Cap. Flow %
-1.54%
Top 10 Hldgs %
31.77%
Holding
144
New
18
Increased
29
Reduced
10
Closed
28

Top Buys

Rank Stock Value
1
BEP icon
Brookfield Renewable
BEP
+$36.7M
2
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$29.3M
3
TREX icon
Trex
TREX
+$26.3M
4
NOVT icon
Novanta
NOVT
+$24.2M
5
DT icon
Dynatrace
DT
+$18.1M

Top Sells

Rank Stock Value
1
TMX
Terminix Global Holdings, Inc.
TMX
+$41.9M
2
PEGI
Pattern Energy Group Inc. Class A
PEGI
+$28.9M
3
ANET icon
Arista Networks
ANET
+$28M
4
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
+$22.6M
5
SRPT icon
Sarepta Therapeutics
SRPT
+$22.5M

Sector Composition

Rank Sector Weight
1 Healthcare 49.63%
2 Technology 22.39%
3 Industrials 9.37%
4 Consumer Discretionary 6.67%
5 Utilities 3.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PAYC icon
51
Paycom
PAYC
$10.2B
$26.5M 0.75%
100,000
-41,000
-29% -$9.7M
TECX
52
Tectonic Therapeutic
TECX
$557M
$26.3M 0.74%
108,776
– –
VCYT icon
53
Veracyte
VCYT
$3.23B
$26M 0.73%
930,000
– –
APTV icon
54
Aptiv
APTV
$9.08B
$25.5M 0.72%
268,700
-17,300
-6% -$1.58M
LEA icon
55
Lear
LEA
$6.22B
$25.2M 0.71%
184,000
– –
NOVT icon
56
Novanta
NOVT
$5.23B
$24.8M 0.7%
+280,000
New +$24.2M
HASI icon
57
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.68B
$24.5M 0.69%
761,500
+51,700
+7% +$1.53M
MNTA
58
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$24.4M 0.69%
1,236,000
– –
CRNX
59
DELISTED
Crinetics Pharmaceuticals
CRNX
$23.8M 0.67%
947,000
– –
AY
60
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
$21M 0.59%
794,600
+8,000
+1% +$200K
DT icon
61
Dynatrace
DT
$15.9B
$20.9M 0.59%
+824,900
New +$18.1M
ESTC icon
62
Elastic
ESTC
$8.94B
$20.6M 0.58%
320,000
+170,000
+113% +$12.5M
PFPT
63
DELISTED
Proofpoint, Inc.
PFPT
$18.1M 0.51%
158,000
– –
XPO icon
64
XPO
XPO
$20.9B
$17.5M 0.49%
636,107
– –
IMVTU
65
DELISTED
Immunovant, Inc. Units
IMVTU
$16.9M 0.48%
+680,000
New +$14.6M
XENE icon
66
Xenon Pharmaceuticals
XENE
$5.45B
$16.7M 0.47%
1,274,100
– –
KRTX
67
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$16.2M 0.46%
214,843
-81,157
-27% -$3.55M
ISRG icon
68
Intuitive Surgical
ISRG
$133B
$14.8M 0.42%
75,000
– –
PHAT icon
69
Phathom Pharmaceuticals
PHAT
$660M
$14M 0.39%
+450,000
New +$11.3M
STRO icon
70
Sutro Biopharma
STRO
$275M
$13.7M 0.39%
124,490
+71,990
+137% +$7.42M
ICPT
71
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$12.4M 0.35%
+100,000
New +$8.95M
MDB icon
72
MongoDB
MDB
$30.4B
$12.2M 0.34%
92,500
– –
EXR icon
73
Extra Space Storage
EXR
$29B
$11.6M 0.33%
110,000
– –
OKTA icon
74
Okta
OKTA
$33.3B
$11.5M 0.33%
100,000
-50,000
-33% -$5.76M
DDOG icon
75
Datadog
DDOG
$82.7B
$11.3M 0.32%
300,000
– –
1 2
3
4 5

Similar funds

S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
CCM
Check Capital Management Costa Mesa, California $7.52B AUM 15.3% 1-Year Est. Return
O
Ossiam Paris, France $7.54B AUM 50.81% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $7.43B AUM 24.49% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
FPP
Findlay Park Partners London, United Kingdom $7.41B AUM 26.32% 1-Year Est. Return
RIG
RiverFront Investment Group Richmond, Virginia $7.56B AUM 23.82% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return

Eventide Asset Management's Q4 2019 Portfolio in Review

As of Q4 2019, Eventide Asset Management held 144 positions worth $3.55B, up 17% from $3.03B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Eventide Asset Management's Q4 2019 filing shows 18 new, 29 increased, 10 reduced and 28 closed positions. Its largest new stake was Trex: 598,000 shares worth $26.9M. The largest sale was Terminix Global Holdings, Inc., an estimated $41.9M.

By sector, the portfolio is most concentrated in Healthcare at 50% of assets, up from 44% a quarter earlier, followed by Technology and Industrials.

  • Eventide Asset Management's largest Q4 2019 buy was Trex: 598,000 shares worth $26.9M.
  • Eventide Asset Management added most to Brookfield Renewable in Q4 2019, an estimated $36.7M increase.
  • Eventide Asset Management's biggest Q4 2019 reduction was Lakefront Biotherapeutics American Depositary Shares, cutting an estimated $22.6M.
  • Eventide Asset Management fully exited Terminix Global Holdings, Inc. in Q4 2019, selling an estimated $41.9M.
  • Eventide Asset Management's ten largest holdings make up 32% of its $3.55B portfolio in Q4 2019.
  • Eventide Asset Management opened 18 new positions and closed 28 in Q4 2019.
  • Eventide Asset Management's portfolio value rose 17% quarter-over-quarter to $3.55B.

Based on Eventide Asset Management's 13F filing for Q4 2019, filed 29 Jan 2020.